drugset / Trial / NCT01858064

Predicting Treatment Response to Stimulants in Adult ADHD Using Functional Magnetic Resonance Imaging

NCT01858064 ↗

Phase 4 Withdrawn Massachusetts General Hospital
NaSingle-groupOpen-labelTreatment

Summary

The primary aim of this study is to assess the predictability of treatment response to stimulants in adults with ADHD using functional magnetic resonance This study will be a six-week, open-label study including adults ranging from age 18-55 with ADHD.

Timeline

Start
2015-04
Primary completion
2015-04
Completion
2015-04

Outcome

Outcome not reported

Stopped: “Competing Departmental Studies”

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylphenidate Small molecule 90 mg —